156 related articles for article (PubMed ID: 38334461)
1. ROR2/Wnt5a Signaling Regulates Directional Cell Migration and Early Tumor Cell Invasion in Ovarian Cancer.
Grither WR; Baker B; Morikis VA; Ilagan MXG; Fuh KC; Longmore GD
Mol Cancer Res; 2024 May; 22(5):495-507. PubMed ID: 38334461
[TBL] [Abstract][Full Text] [Related]
2. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
3. WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3.
Arabzadeh S; Hossein G; Salehi-Dulabi Z; Zarnani AH
Cell Mol Biol Lett; 2016; 21():9. PubMed ID: 28536612
[TBL] [Abstract][Full Text] [Related]
4. Wnt5A regulates the expression of ROR2 tyrosine kinase receptor in ovarian cancer cells.
Hossein G; Arabzadeh S; Salehi-Dulabi Z; Dehghani-Ghobadi Z; Heidarian Y; Talebi-Juybari M
Biochem Cell Biol; 2017 Dec; 95(6):609-615. PubMed ID: 28538104
[TBL] [Abstract][Full Text] [Related]
5. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling.
Wan J; Liu Y; Long F; Tian J; Zhang C
Cancer Sci; 2021 May; 112(5):1707-1722. PubMed ID: 33369809
[TBL] [Abstract][Full Text] [Related]
6. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT
Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008
[TBL] [Abstract][Full Text] [Related]
7. Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma.
Wang L; Yang D; Wang YH; Li X; Gao HM; Lv JY; Wang L; Xin SJ
Tumour Biol; 2016 May; 37(5):6085-90. PubMed ID: 26608372
[TBL] [Abstract][Full Text] [Related]
8. Role of the Ror family receptors in Wnt5a signaling.
Kamizaki K; Minami Y; Nishita M
In Vitro Cell Dev Biol Anim; 2024 May; 60(5):489-501. PubMed ID: 38587578
[TBL] [Abstract][Full Text] [Related]
9. Spinal Wnt5a Plays a Key Role in Spinal Dendritic Spine Remodeling in Neuropathic and Inflammatory Pain Models and in the Proalgesic Effects of Peripheral Wnt3a.
Simonetti M; Kuner R
J Neurosci; 2020 Aug; 40(35):6664-6677. PubMed ID: 32616667
[TBL] [Abstract][Full Text] [Related]
10. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
[TBL] [Abstract][Full Text] [Related]
11. Insight into the role of Wnt5a-induced signaling in normal and cancer cells.
Endo M; Nishita M; Fujii M; Minami Y
Int Rev Cell Mol Biol; 2015; 314():117-48. PubMed ID: 25619716
[TBL] [Abstract][Full Text] [Related]
12. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of WNT5A/ROR2 Signaling Characterizes the Progression of Barrett-Associated Esophageal Adenocarcinoma.
Lyros O; Nie L; Moore T; Medda R; Otterson M; Behmaram B; Mackinnon A; Gockel I; Shaker R; Rafiee P
Mol Cancer Res; 2016 Jul; 14(7):647-59. PubMed ID: 27084312
[TBL] [Abstract][Full Text] [Related]
14. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
[TBL] [Abstract][Full Text] [Related]
15. Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis.
Asem M; Young AM; Oyama C; Claure De La Zerda A; Liu Y; Yang J; Hilliard TS; Johnson J; Harper EI; Guldner I; Zhang S; Page-Mayberry T; Kaliney WJ; Stack MS
Cancer Res; 2020 Mar; 80(5):1156-1170. PubMed ID: 31932454
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of Ror2 suppresses TNF‑α‑induced inflammation and apoptosis in vascular endothelial cells.
Yang X; Zhao S; Yuan H; Shi R; Gu W; Gu Z; Lu X; Zhao H
Mol Med Rep; 2020 Oct; 22(4):2981-2989. PubMed ID: 32945438
[TBL] [Abstract][Full Text] [Related]
17. Lef1 regulates caveolin expression and caveolin dependent endocytosis, a process necessary for Wnt5a/Ror2 signaling during Xenopus gastrulation.
Puzik K; Tonnier V; Opper I; Eckert A; Zhou L; Kratzer MC; Noble FL; Nienhaus GU; Gradl D
Sci Rep; 2019 Oct; 9(1):15645. PubMed ID: 31666627
[TBL] [Abstract][Full Text] [Related]
18. The role of WNT5A and Ror2 in peritoneal membrane injury.
Padwal M; Liu L; Margetts PJ
J Cell Mol Med; 2020 Mar; 24(6):3481-3491. PubMed ID: 32052562
[TBL] [Abstract][Full Text] [Related]
19. Wnt5a suppresses osteoblastic differentiation of human periodontal ligament stem cell-like cells via Ror2/JNK signaling.
Hasegawa D; Wada N; Yoshida S; Mitarai H; Arima M; Tomokiyo A; Hamano S; Sugii H; Maeda H
J Cell Physiol; 2018 Feb; 233(2):1752-1762. PubMed ID: 28681925
[TBL] [Abstract][Full Text] [Related]
20. Wnt5a: A promising therapeutic target in ovarian cancer.
Zhou W; Mei J; Gu D; Xu J; Wang R; Wang H; Liu C
Pathol Res Pract; 2021 Mar; 219():153348. PubMed ID: 33540373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]